Aucta Pharmaceuticals
↗Basking Ridge, New Jersey, USA
Aucta Pharmaceuticals is a research and technology-based specialty pharmaceutical company founded in 2012, focusing on the development and commercialization of niche generic and branded specialty products. The company specializes in creating new therapeutics from proven molecules through innovative formulation strategies, employing the FDA's 505(b)(2) regulatory pathway to develop new dosage forms, dosing regimens, and indications with lower scientific risk. Operating dual R&D hubs in New Jersey (Basking Ridge) and Shanghai, Aucta combines global scientific talent with commercial expertise to address unmet medical needs in CNS disorders, dermatology, ophthalmology, and rare diseases.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Specialty Pharmaceuticals & Generics
SIZE & FINANCIALS
Employees:51-200
Revenue:$10.3M estimated
Founded:2012
Ownership:private
Status:operating
FUNDING
Stage:Series A (completed)
Total Raised:$68.6M
Investors:DNV Capital, Baopu Capital, C&D Emerging Investment, Hidea Venture Capital, Beijing Zhengtai Sunshine Equity Investment Fund Management, Tianjin Haida Venture Capital Management (Series A lead, CNY100M)
PIPELINE
Stage:Commercial | Phase 2 | Preclinical
Lead Drug Stage:MOTPOLY XR (Commercial - launched Feb 2024)
Modalities:Small molecule, Specialty generics, Novel formulations
Active Trials:1
Trial Phases:Phase 2: 1
FDA Approvals:4
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Shanghai Aucta Pharmaceuticals Co., Ltd.
Key Partnerships:Oakrum Pharma - Product development and commercialization partnership for generic deferasirox (JADENU Sprinkle)
COMPETITION
Position:Niche Player
Competitors:Laboratory Research and Innovation Group (LRIG), Averitas Pharma, Somerset Therapeutics, Velesco Pharmaceutical Services, Banner Life Sciences, Sofpromed
LEADERSHIP
Key Executives:
Shoufeng Li - Founder & CEO
Brian Zorn - Chief Commercial Officer
Qiaolin Ren - Vice President, Research & Development
Santangelo - SVP/VP Generics
Jarman - VP Managed Markets & Contracting
Gong - VP Analytical Development & Quality
Scientific Founders:Shoufeng Li, PhD (Founder & CEO)
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Aucta Pharmaceuticals and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Aucta Pharmaceuticals. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.